Panacea Biotec Limited Market Business Overview and Analysis, Research and Development, Pipeline Review 2016
Global Markets Direct's, 'Panacea Biotec Limited - Product Pipeline Review - 2016', provides an overview of the Panacea Biotec Limited's pharmaceutical research and development focus.
Global Markets Direct's, 'Panacea Biotec Limited - Product Pipeline Review - 2016', provides an overview of the Panacea Biotec Limited's pharmaceutical research and development focus.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> <strong>Market</strong> Outlook, <strong>Business</strong> <strong>Overview</strong><br />
<strong>and</strong> <strong>Analysis</strong>, <strong>Research</strong> <strong>and</strong> <strong>Development</strong>, <strong>Pipeline</strong> <strong>Review</strong><br />
<strong>2016</strong><br />
Summary<br />
Global <strong>Market</strong>s Direct's, '<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Product <strong>Pipeline</strong> <strong>Review</strong> - <strong>2016</strong>', provides an overview of the<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s pharmaceutical research <strong>and</strong> development focus.<br />
The report provides comprehensive information on the therapeutics under development by <strong>Panacea</strong> <strong>Biotec</strong><br />
<strong>Limited</strong>, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of<br />
administration (RoA) <strong>and</strong> molecule type. The report also covers the descriptive pharmacological action of the<br />
therapeutics, its complete research <strong>and</strong> development history <strong>and</strong> the dormant <strong>and</strong> discontinued projects.<br />
Global <strong>Market</strong>s Direct's report features investigational drugs from across globe covering over 20 therapy areas <strong>and</strong><br />
nearly 3,000 indications. The report is built using data <strong>and</strong> information sourced from Global <strong>Market</strong>s Direct's<br />
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor<br />
presentations <strong>and</strong> featured press releases from company/university sites <strong>and</strong> industry-specific third party sources.<br />
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that<br />
all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes<br />
ensure that the most recent developments are captured on a real time basis.<br />
Access Full Report with TOC @ http://www.radiantinsights.com/research/panacea-biotec-limited-productpipeline-review-<strong>2016</strong><br />
The report helps in identifying <strong>and</strong> tracking emerging players in the market <strong>and</strong> their portfolios, enhances decision<br />
making capabilities <strong>and</strong> helps to create effective counter strategies to gain competitive advantage.<br />
Note*: Certain sections in the report may be removed or altered based on the availability <strong>and</strong> relevance of data.<br />
Scope<br />
- The report provides a snapshot of the pipeline therapeutic l<strong>and</strong>scape of <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong><br />
- The report provides overview of <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> including its business description, key facts, <strong>and</strong> locations<br />
<strong>and</strong> subsidiaries<br />
- The report features descriptive drug profiles for the pipeline products which includes, product description,<br />
descriptive MoA, R&D brief, licensing <strong>and</strong> collaboration details & other developmental activities<br />
- The report covers pipeline products based on various stages of development ranging from pre-registration till<br />
discovery <strong>and</strong> undisclosed stages
- The report assesses <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s pipeline therapeutics based on drug target, mechanism of action<br />
(MoA), route of administration (RoA) <strong>and</strong> molecule type<br />
- The report features <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s out-licensed <strong>and</strong> partnered product portfolio <strong>and</strong> summarizes its<br />
dormant <strong>and</strong> discontinued projects<br />
Reasons To Buy<br />
- Evaluate <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s strategic position with total access to detailed information on its product<br />
pipeline<br />
- Gain strategically significant competitor information, analysis, <strong>and</strong> insights to formulate effective R&D strategies<br />
- Identify emerging players with potentially strong product portfolio <strong>and</strong> create effective counter-strategies to gain<br />
competitive advantage<br />
- Identify <strong>and</strong> underst<strong>and</strong> important <strong>and</strong> diverse types of therapeutics under development for <strong>Panacea</strong> <strong>Biotec</strong><br />
<strong>Limited</strong><br />
- Identify potential new clients or partners in the target demographic<br />
- Plan mergers <strong>and</strong> acquisitions effectively by identifying key players <strong>and</strong> it's most promising pipeline therapeutics<br />
- Devise corrective measures for pipeline projects by underst<strong>and</strong>ing <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s pipeline depth <strong>and</strong><br />
focus of pipeline therapeutics<br />
- Develop <strong>and</strong> design in-licensing <strong>and</strong> out-licensing strategies by identifying prospective partners with the most<br />
attractive projects to enhance <strong>and</strong> exp<strong>and</strong> business potential <strong>and</strong> scope<br />
Buy a Sample copy of This Report @ http://www.radiantinsights.com/research/panacea-biotec-limited-productpipeline-review-<strong>2016</strong>/request-sample<br />
Table of Contents<br />
Table of Contents 2<br />
List of Tables 5<br />
List of Figures 6<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> Snapshot 7<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> <strong>Overview</strong> 7<br />
Key Information 7<br />
Key Facts 7<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - <strong>Research</strong> <strong>and</strong> <strong>Development</strong> <strong>Overview</strong> 8<br />
Key Therapeutic Areas 8<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - <strong>Pipeline</strong> <strong>Review</strong> 12<br />
<strong>Pipeline</strong> Products by Stage of <strong>Development</strong> 12<br />
<strong>Pipeline</strong> Products - Monotherapy 13<br />
<strong>Pipeline</strong> Products - Combination Treatment Modalities 14<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - <strong>Pipeline</strong> Products Glance 15<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Late Stage <strong>Pipeline</strong> Products 15<br />
Phase III Products/Combination Treatment Modalities 15<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Clinical Stage <strong>Pipeline</strong> Products 16<br />
Phase II Products/Combination Treatment Modalities 16<br />
Phase I Products/Combination Treatment Modalities 17<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Early Stage <strong>Pipeline</strong> Products 18<br />
Preclinical Products/Combination Treatment Modalities 18<br />
Discovery Products/Combination Treatment Modalities 19<br />
<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Unknown Stage <strong>Pipeline</strong> Products 20<br />
Unknown Products/Combination Treatment Modalities 20<br />
Access Full Report with TOC @ http://www.radiantinsights.com/research/panacea-biotec-limited-productpipeline-review-<strong>2016</strong>
About Us:<br />
Radiant Insights Inc. is a platform for companies looking to meet their market research <strong>and</strong> business intelligence<br />
requirements. We assist <strong>and</strong> facilitate organizations <strong>and</strong> individuals procure market research reports, helping them<br />
in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries<br />
<strong>and</strong> a host of micro markets. In addition to over extensive database of reports, our experienced research<br />
coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups <strong>and</strong> customized research<br />
solutions.<br />
Contact Details:<br />
Michelle Thoras<br />
Corporate Sales Specialist, USA<br />
Radiant Insights, Inc<br />
28 2nd Street,<br />
Suite 3036 San Francisco,<br />
CA 94105 United States<br />
Phone: 1-415-349-0054<br />
Toll Free: 1-888-202-9519<br />
Website: http://www.radiantinsights.com/<br />
Email: sales@radiantinsights.com<br />
Visit our Blog: http://chemicals<strong>and</strong>materialsri.blogspot.com
Change language